-interest income was Baht 11.7 billion, an increase of 7.0 percent, due predominantly to gains on investments and net fees and service income, contributed mainly by mutual funds, bancassurance, and loan
additional investments in plant, machinery, and office renovations to improve production efficiency and reduce production cost, for the Company’s sustainable growth in the future. However, some investments
net interest margin of 2.38 percent, and an increase of 15.7 percent in non-interest income contributed by increases in gains on trading and foreign exchange transactions, gains on investments and net
Expenses (130.8) (152.9) -14.5% Finance Costs (366.6) (459.9) -20.3% Share of Profit from Investments in Associates and Joint Ventures 2,047.4 1,936.1 5.7% Income Tax (Expense) Income (49.1) (18.2) 170.4
% Normalized Net Profit/4 226.3* 457.1 102.0% 1,140.2* 1,720.9 50.9% /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from
% Administrative Expenses (42.8) (37.5) 14.3% (118.6) (82.4) 44.0% Finance Costs (84.4) (84.2) 0.3% (245.5) (282.7) -13.2% Share of Profit from Investments in Associates and Joint Ventures 418.5 547.3 -23.5% 1,510.4
Total current assets 34.74 53.37 42.11 Long-term investments 0.60 0.60 6.00 Property, plant and equipment – net 202.21 189.14 187.16 บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอ
equivalents 2.14 2.02 5.85 Trade and other receivables 16.37 19.59 18.62 Inventories 14.04 12.92 10.87 Other current assets 2.18 18.82 6.75 Total current assets 34.74 53.37 42.11 Long-term investments 0.60 0.60
increase of Baht 319 million from the first quarter of 2019. Non-interest income rose by Baht 3,206 million or 31.0 percent, due mainly to increases in gains on investments and dividend income, while net
in 2016 mainly from the provision expenses. - Share of profit from investments in joint ventures in 2017 amounted 35.72 million baht while there were share of loss from investments in joint ventures